6月29日，中国医疗医械生产商康基医疗于港交所成功上市，共募资约31.3亿港元。盛德律师事务所、天元律师事务所为发行人提供法律意见，苏利文·克伦威尔律师事务所、金杜律师事务所则代表联席保荐人参与交易。

根据天元的一份新闻稿，该项目是今年度最大的医疗器械行业企业香港IPO，此外，康基医疗在冻资额及认购人数上，均成为今年以来的“新股双料王”。

2004年成立于杭州，康基医疗是中国目前最大的微创外科手术器械及配件生产商，其产品主要应用于妇产科、泌尿外科、普外科以及胸外科等外科专科领域。

迈普达律师事务所就开曼群岛法律为发行人提供意见。

高盛、中信里昂及美银美林担任本次发行项目的联席保荐人。

盛德团队项目牵头律师为合伙人吕梦宇、丁锰律师。

Tian Yuan, Sidley, KWM, Sullivan on 2020’s largest medical instrument HK IPO to date

Sidley Austin and Tian Yuan Law Firm have advised China medical instrument manufacturer Kangji Medical on its $404 million initial public offering in Hong Kong, with Sullivan & Cromwell and King & Wood Mallesons acting for the joint sponsors.

This is the largest IPO to date in 2020 of the medical instrument industry in Hong Kong.

Founded in 2004 in Hangzhou, Kangji Medical is the largest domestic minimally invasive surgical instruments and accessories developer and manufacturer in China, with its products being widely used in  OBGYN, general surgery, urology and thoracic surgery.

Maples and Calder acted as offshore legal counsel to the issuer.

The Sidley team was led by partners Lv Mengyu, Ding Meng.

To contact the editorial team, please email ALBEditor@thomsonreuters.com.